Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Clinical trial NCT06526000 · COMPLETED

Trial details

NCT number: NCT06526000
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis Clinically Isolated Syndrome Relapsing-remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2022-10-11
Primary completion: 2024-02-28
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.